As a leading CRO with a presence in Asia Pacific since 1996, local know-how is our specialty.
Our experts understand the unique challenges of conducting research in Asia Pacific and use their country-specific knowledge to ensure we deliver quality data to our clients on time and within budget.
ICON has over 2,800 professionals working in 13 countries in the region, committed to helping pharma and biotech clients make informed decisions faster. We have the capability and expertise to conduct clinical trials and development projects on both a local, cross region and global basis.
We provide a full range of services:
At ICON, we use our insight and innovation to drive measurable performance improvements. Our operational capability and therapeutic expertise enable us to deliver value and operational excellence in drug development projects, which translates into constantly exceeding client expectations.
Why Asia Pacific
A number of factors contribute to Asia Pacific being an excellent location for clinical trials:
Use our country comparison tool for in-depth detail on Health Trends, the clinical trials landscape, Regulatory information and patient sites.
Sources: The Changing Dynamics of Pharma Outsourcing in Asia: Are you readjusting your sights? by PWC